Salome Mekhuzla: Representing WFH’s Voice in Front of WHO Leadership and National Governments
Salome Mekhuzla, Director of Global Development at the World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Read the WFH open letter to the WHO Director-General in support for the draft resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders here!
This landmark resolution is scheduled to be discussed at the 158th session of the WHO Executive Board, February 2nd, tentatively in the afternoon central european time, so morning hours for those in EST time zone. The WFH will be participating at this session and we will deliver a statement to represent our global community’s voice in front of WHO leadership and national governments!
Keep an eye on our social media posts on Monday, as we will share a web link for anyone interested to follow this discussion live.”
Quoting World Federation of Hemophilia’s post:
“The World Federation of Hemophilia has formally presented a letter to the WHO Director-General, urging support for a World Health Assembly resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders.
This global call highlights the ongoing gaps in diagnosis, treatment, and care, and the urgent need for coordinated action so access to care no longer depends on where someone lives.
The draft resolution is tabled for discussion at the 158th Session of the WHO Executive Board (EB158) in Geneva during February 2 to 7, 2026. The WFH commands leadership of WHO Member States in driving this resolution adoption process: Armenia as lead Member States, and co-sponsored by Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo. The WFH also thanks all member and partner organizations who have joined the WFH’s Global Call for Health Equity for Bleeding Disorders in support of the landmark resolution.
More posts featuring Salome Mekhuzla.
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand